• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Delayed-onset psoriasiform eruption secondary to a phosphoinositide 3-kinase inhibitor: A case report and literature review.

作者信息

Tran Duy C, Karim Maria, Lo Sicco Kristen, Brinster Nooshin, Milam Emily C, Tattersall Ian W

机构信息

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.

Hackensack Meridian School of Medicine, Nutley, New Jersey.

出版信息

JAAD Case Rep. 2022 Apr 1;24:97-100. doi: 10.1016/j.jdcr.2022.02.043. eCollection 2022 Jun.

DOI:10.1016/j.jdcr.2022.02.043
PMID:35647250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9136599/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe8/9136599/66cb8e141732/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe8/9136599/f49fef7e509e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe8/9136599/0d722053cfd6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe8/9136599/66cb8e141732/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe8/9136599/f49fef7e509e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe8/9136599/0d722053cfd6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe8/9136599/66cb8e141732/gr3.jpg

相似文献

1
Delayed-onset psoriasiform eruption secondary to a phosphoinositide 3-kinase inhibitor: A case report and literature review.磷酸肌醇3-激酶抑制剂继发的迟发性银屑病样皮疹：一例报告及文献复习
JAAD Case Rep. 2022 Apr 1;24:97-100. doi: 10.1016/j.jdcr.2022.02.043. eCollection 2022 Jun.
2
[A new case of pityriasis rubra pilaris-like eruption associated with ponatinib, a tyrosine kinase inhibitor].[一例与酪氨酸激酶抑制剂波纳替尼相关的毛发红糠疹样皮疹新病例]
Ann Dermatol Venereol. 2018 Nov;145(11):665-670. doi: 10.1016/j.annder.2018.04.009. Epub 2018 Jun 11.
3
Follicular Psoriasis: Differentiation from Pityriasis Rubra Pilaris-An Illustrative Case and Review of the Literature.毛囊性银屑病：与毛发红糠疹的鉴别——1例病例报告及文献复习
Pediatr Dermatol. 2017 Jan;34(1):e65-e68. doi: 10.1111/pde.13030. Epub 2016 Nov 22.
4
Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.甲氨蝶呤治疗一例青少年毛发红糠疹。
Pediatr Dermatol. 2018 Jan;35(1):e62-e63. doi: 10.1111/pde.13326. Epub 2017 Oct 17.
5
Recalcitrant psoriasiform dermatosis of the face: Is it related to pityriasis rubra pilaris?面部顽固性银屑病样皮肤病：它与毛发红糠疹有关吗？
J Cutan Pathol. 2018 Jul;45(7):491-497. doi: 10.1111/cup.13148. Epub 2018 Apr 23.
6
Pityriasis rubra pilaris with acantholysis.伴有棘层松解的红皮病型毛发红糠疹。
J Cutan Pathol. 1996 Jun;23(3):270-4. doi: 10.1111/j.1600-0560.1996.tb01478.x.
7
A case of resistant pityriasis ribra pilaris responsive to combination acitrentin and ustekinumab.一例对阿维A与乌司奴单抗联合治疗有效的难治性毛发红糠疹病例。
Dermatol Online J. 2020 Mar 15;26(3):13030/qt1712g0gm.
8
Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition.磷酯酰肌醇 3-激酶抑制继发棘层松解性红皮病样皮炎。
Clin Exp Dermatol. 2018 Dec;43(8):890-894. doi: 10.1111/ced.13608. Epub 2018 May 30.
9
Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis.伴毛发红糠疹样皮疹的皮肌炎：皮肌炎中一种不常见的皮肤表现
Pediatr Dermatol. 2007 Mar-Apr;24(2):151-4. doi: 10.1111/j.1525-1470.2007.00364.x.
10
Histopathologic findings characteristic of CARD14-associated papulosquamous eruption.具有 CARD14 相关丘疹鳞屑性疹的组织病理学特征。
J Cutan Pathol. 2020 May;47(5):425-430. doi: 10.1111/cup.13633. Epub 2019 Dec 26.

本文引用的文献

1
Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?PI3K-δ抑制剂继发的银屑病样皮疹：银屑病样矛盾反应的范围正在扩大？
Acta Derm Venereol. 2021 Mar 18;101(3):adv00418. doi: 10.2340/00015555-3783.
2
Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report.一名难治性滤泡性淋巴瘤患者接受idelalisib单药治疗时出现银屑病样皮疹的管理：病例报告
J Med Case Rep. 2020 Feb 24;14(1):35. doi: 10.1186/s13256-020-2344-9.
3
Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition.
继发于磷酸肌醇3激酶抑制的银屑病样皮疹
JAAD Case Rep. 2019 Apr 20;5(5):401-405. doi: 10.1016/j.jdcr.2018.03.005. eCollection 2019 May.
4
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.DUO 试验 3 期：在复发/难治性 CLL/SLL 中比较度维利塞与奥法妥木单抗。
Blood. 2018 Dec 6;132(23):2446-2455. doi: 10.1182/blood-2018-05-850461. Epub 2018 Oct 4.
5
Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition.磷酯酰肌醇 3-激酶抑制继发棘层松解性红皮病样皮炎。
Clin Exp Dermatol. 2018 Dec;43(8):890-894. doi: 10.1111/ced.13608. Epub 2018 May 30.
6
PI3K Inhibitors: Understanding Toxicity Mechanisms and Management.PI3K抑制剂：了解毒性机制与管理
Oncology (Williston Park). 2017 Nov 15;31(11):821-8.
7
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.癌症中的PI3K：异构体的不同作用、激活模式及治疗靶点
Nat Rev Cancer. 2015 Jan;15(1):7-24. doi: 10.1038/nrc3860.
8
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis.甲氧苄啶-磺胺甲恶唑诱发红皮病型银屑病。
J Infect. 2008 Jul;57(1):90-2. doi: 10.1016/j.jinf.2008.04.005. Epub 2008 May 21.
9
Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting.社区卫生环境中的药物不良反应：识别、咨询及报告方法
Fam Community Health. 1982 Aug;5(2):58-67. doi: 10.1097/00003727-198208000-00009.
10
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.